Işık Görker1, Hakan Gürkan2, Selma Ulusal2, Engin Atli2, Güçlü Ayaz3, Cansın Ceylan4, Hilmi Tozkir2, Mengühan Araz Altay5, Ali Erol1, Nazike Yildiz1, Ceren Direk1, Hilal Akköprü6, Neriman Kilit7, Hasan Cem Aykutlu1, Leyla Bozatli1, Zeki Çelik8, Kıvanç Kudret Berberoğlu1. 1. Department of Child and Adolescent Psychiatry, Trakya University Faculty of Medicine, Edirne, Turkey. 2. Department of Medical Genetics, Trakya University, Edirne, Turkey. 3. Department of Child and Adolescent Psychiatry, Samsun Education and Research Hospital, Samsun, Turkey. 4. Department of Child and Adolescent Psychiatry, Kırklareli State Hospital, Kırklareli, Turkey. 5. Department of Child and Adolescent Psychiatry, Edirne Sultan 1. Murat State Hospital, Edirne, Turkey. 6. Department of Child and Adolescent Psychiatry, Istanbul University Faculty of Medicine, Istanbul, Turkey. 7. Department of Child and Adolescent Psychiatry, Osmangazi University Faculty of Medicine, Eskişehir, Turkey. 8. Department of Child and Adolescent Psychiatry, Diyarbakır Children Hospital, Diyarbakır Turkey.
Abstract
AIM: The development of whole-genome screening methodologies for the detection of copy number variations (CNVs), such as array-based comparative genomic hybridization (aCHG), provides a much higher resolution than karyotyping leading to the identification of novel microdeletion and microduplication syndromes often associated with an autism spectrum disease (ASD) phenotype. The aim of the study was to determine CNVs of patients with ASD by using array-based comparative genomic hybridization. METHODS: Fifty-three patients diagnosed with ASD between 20.01.2014 and 14.01.2015 were included in the study. Chromosome analysis of the patients was performed from peripheral blood cultures and analysed as normal. All patients were evaluated with P064C1 and P096A2 MLPA probes in terms of 16 mental retardation related syndromes. For aCGH method, SurePrint G3 Human microarrays 8x60K were used with genomic DNA isolated from peripheral blood. RESULTS: According to results of 53 patients who were included in and performed with arrayCGH, 8 (15%) patients had CNVs classified as pathogenic or variant of unknown significance (VOUS) in the study. We detected a pathogenic NRXN1 gene partial CNV deletion (2p16.3) in two patients. Also we identified a 900 kb duplication of 4p15.31 including SLIT2 gene, and a 245 kb duplication of 15q11.2 including PWRN1 gene in one patient. Our other findings are considered to be a variant of unknown significance (VOUS). CONCLUSION: The results of the study support the literature knowledge, where the copy number variations that cannot be detected with conventional cytogenetics methods in terms of size may happen in patients with ASD.
AIM: The development of whole-genome screening methodologies for the detection of copy number variations (CNVs), such as array-based comparative genomic hybridization (aCHG), provides a much higher resolution than karyotyping leading to the identification of novel microdeletion and microduplication syndromes often associated with an autism spectrum disease (ASD) phenotype. The aim of the study was to determine CNVs of patients with ASD by using array-based comparative genomic hybridization. METHODS: Fifty-three patients diagnosed with ASD between 20.01.2014 and 14.01.2015 were included in the study. Chromosome analysis of the patients was performed from peripheral blood cultures and analysed as normal. All patients were evaluated with P064C1 and P096A2 MLPA probes in terms of 16 mental retardation related syndromes. For aCGH method, SurePrint G3 Human microarrays 8x60K were used with genomic DNA isolated from peripheral blood. RESULTS: According to results of 53 patients who were included in and performed with arrayCGH, 8 (15%) patients had CNVs classified as pathogenic or variant of unknown significance (VOUS) in the study. We detected a pathogenic NRXN1 gene partial CNV deletion (2p16.3) in two patients. Also we identified a 900 kb duplication of 4p15.31 including SLIT2 gene, and a 245 kb duplication of 15q11.2 including PWRN1 gene in one patient. Our other findings are considered to be a variant of unknown significance (VOUS). CONCLUSION: The results of the study support the literature knowledge, where the copy number variations that cannot be detected with conventional cytogenetics methods in terms of size may happen in patients with ASD.
Entities:
Keywords:
Autism; copy number variations; genomic hybridization; karyotype; microarrays
Authors: Rachel M Jones; Gemma Cadby; John Blangero; Lawrence J Abraham; Andrew J O Whitehouse; Eric K Moses Journal: Psychiatr Genet Date: 2014-12 Impact factor: 2.458
Authors: Mei Han; Rebeca Mejias; Shu-Ling Chiu; Rebecca Rose; Abby Adamczyk; Richard Huganir; Tao Wang Journal: Behav Brain Res Date: 2017-01-04 Impact factor: 3.332
Authors: Rebeca Mejias; Abby Adamczyk; Victor Anggono; Tejasvi Niranjan; Gareth M Thomas; Kamal Sharma; Cindy Skinner; Charles E Schwartz; Roger E Stevenson; M Daniele Fallin; Walter Kaufmann; Mikhail Pletnikov; David Valle; Richard L Huganir; Tao Wang Journal: Proc Natl Acad Sci U S A Date: 2011-03-07 Impact factor: 11.205
Authors: Elena Bacchelli; Agatino Battaglia; Cinzia Cameli; Silvia Lomartire; Raffaella Tancredi; Susanne Thomson; James S Sutcliffe; Elena Maestrini Journal: Am J Med Genet A Date: 2015-02-05 Impact factor: 2.802
Authors: Julia C Geiger; Joanna Lipka; Inmaculada Segura; Susanne Hoyer; Max A Schlager; Phebe S Wulf; Stefan Weinges; Jeroen Demmers; Casper C Hoogenraad; Amparo Acker-Palmer Journal: Dev Cell Date: 2014-02-24 Impact factor: 12.270
Authors: Claire S Leblond; Jutta Heinrich; Richard Delorme; Christian Proepper; Catalina Betancur; Guillaume Huguet; Marina Konyukh; Pauline Chaste; Elodie Ey; Maria Rastam; Henrik Anckarsäter; Gudrun Nygren; I Carina Gillberg; Jonas Melke; Roberto Toro; Beatrice Regnault; Fabien Fauchereau; Oriane Mercati; Nathalie Lemière; David Skuse; Martin Poot; Richard Holt; Anthony P Monaco; Irma Järvelä; Katri Kantojärvi; Raija Vanhala; Sarah Curran; David A Collier; Patrick Bolton; Andreas Chiocchetti; Sabine M Klauck; Fritz Poustka; Christine M Freitag; Regina Waltes; Marnie Kopp; Eftichia Duketis; Elena Bacchelli; Fiorella Minopoli; Liliana Ruta; Agatino Battaglia; Luigi Mazzone; Elena Maestrini; Ana F Sequeira; Barbara Oliveira; Astrid Vicente; Guiomar Oliveira; Dalila Pinto; Stephen W Scherer; Diana Zelenika; Marc Delepine; Mark Lathrop; Dominique Bonneau; Vincent Guinchat; Françoise Devillard; Brigitte Assouline; Marie-Christine Mouren; Marion Leboyer; Christopher Gillberg; Tobias M Boeckers; Thomas Bourgeron Journal: PLoS Genet Date: 2012-02-09 Impact factor: 5.917
Authors: Yiping Shen; Kira A Dies; Ingrid A Holm; Carolyn Bridgemohan; Magdi M Sobeih; Elizabeth B Caronna; Karen J Miller; Jean A Frazier; Iris Silverstein; Jonathan Picker; Laura Weissman; Peter Raffalli; Shafali Jeste; Laurie A Demmer; Heather K Peters; Stephanie J Brewster; Sara J Kowalczyk; Beth Rosen-Sheidley; Caroline McGowan; Andrew W Duda; Sharyn A Lincoln; Kathryn R Lowe; Alison Schonwald; Michael Robbins; Fuki Hisama; Robert Wolff; Ronald Becker; Ramzi Nasir; David K Urion; Jeff M Milunsky; Leonard Rappaport; James F Gusella; Christopher A Walsh; Bai-Lin Wu; David T Miller Journal: Pediatrics Date: 2010-03-15 Impact factor: 7.124